Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results

BackgroundSecretoneurin (SN) is a neuropeptide with potential utility as a biomarker of cardiovascular episodes. The main effect of SN is mediated through its inhibition of calmodulin-dependent kinase II (CaMKII), which influences calcium handling. We aimed to associate the levels of SN in plasma wi...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Dana Purová, Jan Václavík
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2024-01-01
Cyfres:	Frontiers in Cardiovascular Medicine
Pynciau:	secretoneurin heart failure CaMKII dilated cardiomyopathy ischaemic cardiomyopathy
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1297900/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!